Literature DB >> 26366258

Postoperative Nausea and Vomiting: Palonosetron with Dexamethasone vs. Ondansetron with Dexamethasone in Laparoscopic Hysterectomies.

Anish N G Sharma1, Paniye Shankaranarayana1.   

Abstract

OBJECTIVES: Postoperative nausea and vomiting (PONV) is the most common complication seen following laparoscopic surgery. Our study sought to evaluate the efficacy of the newer drug palonosetron with that of ondansetron, in combination with dexamethasone, for PONV in patients undergoing laparoscopic hysterectomies. .
METHODS: A total of 90 patients, aged between 30-50 years old, posted for elective laparoscopic hysterectomies under general anesthesia belonging to the American Society of Anesthesiologist (ASA) physical status I and II were included in the study. Patients were randomly divided into one of two groups (n=45). Before induction, patients in the first group (group I) received 0.075mg palonosetron with 8mg dexamethasone and patients in the second group (group II) received 4mg ondansetron with 8mg dexamethasone. Postoperatively, any incidences of early or delayed vomiting, requirement of rescue antiemetic, and side effects were recorded. Patient's hemodynamics were also monitored. Statistical analysis was done using Student's t-test, chi-square test, and Fisher's exact test. .
RESULTS: Preoperative, intraoperative, and postoperative heart rate, mean arterial pressure, peripheral capillary oxygen saturation were statistically not significant (p>0.050) in either group. In group II, eight patients had nausea in the first two hours and three patients had nausea in the two to six-hour postoperative period. In group I, three patients experienced nausea in the first six hours period. Eight patients in group II had vomited in the first two-hour period compared to one patient in group I (p=0.013). The requirement of rescue antiemetic was greater in group II than group I (20% vs. 4%). No side effects of antiemetic use were observed in either group. .
CONCLUSION: The combination of palonosetron with dexamethasone is more effective in treating early, delayed, and long term PONV compared to ondansetron with dexamethasone in patients undergoing elective laparoscopic hysterectomies under general anesthesia.

Entities:  

Keywords:  Dexamethasone; Hysterectomy; Laparoscopy; Ondansetron; Palonosetron

Year:  2015        PMID: 26366258      PMCID: PMC4561637          DOI: 10.5001/omj.2015.51

Source DB:  PubMed          Journal:  Oman Med J        ISSN: 1999-768X


  26 in total

1.  Unanticipated admission to the hospital following ambulatory surgery.

Authors:  B S Gold; D S Kitz; J H Lecky; J M Neuhaus
Journal:  JAMA       Date:  1989-12-01       Impact factor: 56.272

Review 2.  Ondansetron: a review of its use as an antiemetic in children.

Authors:  C R Culy; N Bhana; G L Plosker
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

3.  Dexamethasone 8 mg in combination with ondansetron 4 mg appears to be the optimal dose for the prevention of nausea and vomiting after laparoscopic cholecystectomy.

Authors:  Mokhtar Elhakim; Magdy Nafie; Khalaf Mahmoud; Azza Atef
Journal:  Can J Anaesth       Date:  2002-11       Impact factor: 5.063

4.  Ramosetron vs granisetron for the prevention of postoperative nausea and vomiting after laparoscopic cholecystectomy.

Authors:  Y Fujii; Y Saitoh; H Tanaka; H Toyooka
Journal:  Can J Anaesth       Date:  1999-10       Impact factor: 5.063

5.  The effect of combining dexamethasone with ondansetron for nausea and vomiting associated with fentanyl-based intravenous patient-controlled analgesia.

Authors:  J W Song; E Y Park; J G Lee; Y S Park; B C Kang; Y H Shim
Journal:  Anaesthesia       Date:  2011-04       Impact factor: 6.955

6.  Assessment of postoperative nausea using a visual analogue scale.

Authors:  J G Boogaerts; E Vanacker; L Seidel; A Albert; F M Bardiau
Journal:  Acta Anaesthesiol Scand       Date:  2000-04       Impact factor: 2.105

7.  Prospective randomized, double-blind comparative study of dexamethasone, ondansetron, and ondansetron plus dexamethasone as prophylactic antiemetic therapy in patients undergoing day-case gynaecological surgery.

Authors:  R Thomas; N Jones
Journal:  Br J Anaesth       Date:  2001-10       Impact factor: 9.166

8.  Nausea and vomiting after gynaecological laparoscopy depends upon the phase of the menstrual cycle.

Authors:  P Honkavaara; A M Lehtinen; J Hovorka; K Korttila
Journal:  Can J Anaesth       Date:  1991-10       Impact factor: 5.063

9.  Evaluation of antiemetic effect of intravenous palonosetron versus intravenous ondansetron in laparoscopic cholecystectomy: a randomized controlled trial.

Authors:  Baisakhi Laha; Avijit Hazra; S Mallick
Journal:  Indian J Pharmacol       Date:  2013 Jan-Feb       Impact factor: 1.200

10.  Palonosetron and palonosetron plus dexamethasone to prevent postoperative nausea and vomiting in patients undergoing laparoscopic cholecystectomy: A prospective, randomized, double-blind comparative study.

Authors:  Soumyendu Ghosh; Anirban Pal; Amita Acharya; Chaitali Biswas; Tirtha Ratan Ghosh; Subhabrata Ghosh
Journal:  Anesth Essays Res       Date:  2011 Jul-Dec
View more
  3 in total

1.  Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.

Authors:  Stephanie Weibel; Gerta Rücker; Leopold Hj Eberhart; Nathan L Pace; Hannah M Hartl; Olivia L Jordan; Debora Mayer; Manuel Riemer; Maximilian S Schaefer; Diana Raj; Insa Backhaus; Antonia Helf; Tobias Schlesinger; Peter Kienbaum; Peter Kranke
Journal:  Cochrane Database Syst Rev       Date:  2020-10-19

2.  Effects of palonosetron and ondansetron on preventing nausea and vomiting after laparoscopic surgery.

Authors:  Qili Liu; Chengmao Zhou; Zeqing Bao; Yu Zhu
Journal:  J Int Med Res       Date:  2017-07-18       Impact factor: 1.671

3.  Comparison of palonosetron and ondansetron to prevent postoperative nausea and vomiting in women using intravenous patient-controlled analgesia.

Authors:  Jae Hwa Yoo; In Suk Jeon; Ji Won Chung; Jae Hoon Ryoo; Gyu Wan You; Soon Im Kim
Journal:  Anesth Pain Med (Seoul)       Date:  2020-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.